Reuters - Video

Edition: US | UK | IN | CN | JP

video Personal Finance

More upside ahead for Biogen, says Jerry Braakman

Friday, July 06, 2018 - 05:59

First American Trust's CIO tells Reuters' Fred Katayama why he's bullish on Biogen's prospects. The biotech firm's stock surged after its Alzheimer's drug showed positive results in a mid-stage trial.

▲ Hide Transcript

View Transcript

First American Trust's CIO tells Reuters' Fred Katayama why he's bullish on Biogen's prospects. The biotech firm's stock surged after its Alzheimer's drug showed positive results in a mid-stage trial.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

More upside ahead for Biogen, says Jerry Braakman

Friday, July 06, 2018 - 05:59